Table 1.

Summary of Clinician Responses to the Survey

	All respondents N=90
Question	N*	%
Pharmacogenomics was part of training/medical education	26/87	30
Talked to a patient about pharmacogenomics results	8/90	9
Plan to use pharmacogenomics results in the future to:†
Guide future prescribing selection when appropriate	32/86	37
Guide future dosing when appropriate	27/86	31
Call for pharmacy consultation	17/86	20
Do not plan to use	6/86	7
Do not know at this time	39/86	45
Expect to order or recommend a pharmacogenomic test in next 6 months	6/87	7
Remembered receiving the informational packet	27/90	30
Informational packet was at least somewhat helpful‡	19/27	70
Remembered seeing a drug-gene alert	37/87	43
Sometimes, often, or always changed the prescription due to alert§	15/37	41
Perception of the PGx-CDS alert§,†
Positive response (alert was helpful, convenient, or easy to understand)	12/36	33
Negative response (alert was confusing, irritating, frustrating, or it was difficult to find additional information)	19/36	53
Both positive and negative responses	5/36	14

^*Non-missing values reported; responders not shown, and not included in the percentages based on non-missing values.

^†Respondents could check all that applied.

^‡Denominator is the 27 participants who remembered receiving the informational packet.

^§Denominator is the 37 participants who remembered seeing a drug-gene alert.